Papillary thyroid carcinoma distant metastasis mutation predicting model, method and system
A technology for papillary carcinoma and distant metastasis, applied in the field of biomedicine, can solve the problem of little research on the molecular mechanism of distant metastasis of papillary thyroid carcinoma, and achieve high specificity, high sensitivity, and high prediction accuracy
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0037] Example 1 Sample selection and process
[0038]One aspect of the research of the present invention is to explore the molecular mechanism of distant metastasis of thyroid papillary carcinoma and the relationship between molecular level variation and clinical traits related to the degree of deterioration. In this batch, a total of 66 primary tumor samples from patients with papillary thyroid carcinoma were subjected to WES and 425gene panel sequencing at the same time.
[0039] The basic clinical information of the sample source is as follows
[0040]
[0041]
[0042] The core phenotype of patients: no metastasis, lymph node metastasis and distant metastasis.
[0043] WES sequencing was performed on primary papillary thyroid carcinoma tissue (n=66), and the clinical information tables were all based on primary cancer tissue.
[0044] The flow chart of the research design is as figure 1 shown.
[0045] At the same time, WES and 425gene panel detection were perfo...
Embodiment 2W
[0048] Example 2 Basic Information of WES Sequencing
[0049] The sequencing quality of 66 cases of papillary thyroid carcinoma in the embodiment of the present invention: the Q30 ratio is 91%.
[0050] Average sequencing depth: 204X, average sequencing depth after PCR dup removal: 167X (min: 109X, max: 208X), follow-up analysis after PCR dup removal.
[0051] Contamination degree estimation: The sample with the highest degree of contamination was 0.2% contamination rate, which had no effect on call mutations.
[0052] All 66 WES samples passed the quality control and entered the follow-up analysis.
Embodiment 3
[0053] Example 3 Molecular Mechanisms Related to Distant Metastasis of Papillary Thyroid Carcinoma
[0054] Such as image 3 As a result, the present invention found that the gene mutation map of thyroid papillary carcinoma shows that BRAF mutation and gene fusion are mutually exclusive.
[0055] BRAF mutations were mainly concentrated in the non-metastasis and lymph node metastases groups.
[0056] Fusion and SCNA were concentrated in the distant metastases group.
[0057] BRAF mutations and fusions were mutually exclusive (p-value<0.0001).
[0058] Of the 66 patients, 59 (89%) had at least one driver event (BRAF, fusion, TERT driver mutation, or Arm SCNA) found.
[0059] Note: BRAF nonsynonymous mutations are all V600E, TERT promoter mutations and fusions are detected by 425Panel.
[0060] Such as Figure 4 The present invention finds that the analysis results of patients with papillary thyroid carcinoma in the TCGA database are more consistent with the results of this ...
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com